Figari I - Search Results

1

TGF-beta: a possible autocrine immune regulator.

Lucas C, Wallick S, Fendly BM, Figari I, Palladino MA. Lucas C, et al. Among authors: figari i. Ciba Found Symp. 1991;157:98-108; discussion 108-14. doi: 10.1002/9780470514061.ch7. Ciba Found Symp. 1991. PMID: 2070686

2

Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1.

Wallick SC, Figari IS, Morris RE, Levinson AD, Palladino MA. Wallick SC, et al. Among authors: figari is. J Exp Med. 1990 Dec 1;172(6):1777-84. doi: 10.1084/jem.172.6.1777. J Exp Med. 1990. PMID: 2258706 Free PMC article.

3

The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA.

Lucas C, Bald LN, Fendly BM, Mora-Worms M, Figari IS, Patzer EJ, Palladino MA. Lucas C, et al. Among authors: figari is. J Immunol. 1990 Sep 1;145(5):1415-22. J Immunol. 1990. PMID: 2384664

4

Possible relationships between in vivo antitumour activity and toxicity of tumour necrosis factor-alpha.

Palladino MA Jr, Patton JS, Figari IS, Shalaby MR. Palladino MA Jr, et al. Among authors: figari is. Ciba Found Symp. 1987;131:21-38. doi: 10.1002/9780470513521.ch3. Ciba Found Symp. 1987. PMID: 3330012 Review.

5

Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic.

Shepard HM, Lewis GD, Sarup JC, Fendly BM, Maneval D, Mordenti J, Figari I, Kotts CE, Palladino MA Jr, Ullrich A, et al. Shepard HM, et al. Among authors: figari i. J Clin Immunol. 1991 May;11(3):117-27. doi: 10.1007/BF00918679. J Clin Immunol. 1991. PMID: 1679763 Review.

6

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.

Lewis GD, Figari I, Fendly B, Wong WL, Carter P, Gorman C, Shepard HM. Lewis GD, et al. Among authors: figari i. Cancer Immunol Immunother. 1993 Sep;37(4):255-63. doi: 10.1007/BF01518520. Cancer Immunol Immunother. 1993. PMID: 8102322 Free PMC article.

7

Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells.

Chang HL, Gillett N, Figari I, Lopez AR, Palladino MA, Derynck R. Chang HL, et al. Among authors: figari i. Cancer Res. 1993 Sep 15;53(18):4391-8. Cancer Res. 1993. PMID: 8364935

8

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.

Ashkenazi A, Marsters SA, Capon DJ, Chamow SM, Figari IS, Pennica D, Goeddel DV, Palladino MA, Smith DH. Ashkenazi A, et al. Among authors: figari is. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10535-9. doi: 10.1073/pnas.88.23.10535. Proc Natl Acad Sci U S A. 1991. PMID: 1660140 Free PMC article.

9

The two different receptors for tumor necrosis factor mediate distinct cellular responses.

Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr, Goeddel DV. Tartaglia LA, et al. Among authors: figari is. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9292-6. doi: 10.1073/pnas.88.20.9292. Proc Natl Acad Sci U S A. 1991. PMID: 1718003 Free PMC article.

10

Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alpha.

Figari IS, Mori NA, Palladino MA Jr. Figari IS, et al. Blood. 1987 Oct;70(4):979-84. Blood. 1987. PMID: 2820532 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters